
GC61843
Mofezolac
Also known as 2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid
Mofezolac, a non-steroidal anti-inflammatory drug (NSAID), is a selective, reversible and orally active COX-1 inhibitor with an IC50 of 1·44 nM
ChemicalCAS78967-07-4MW339.34FormulaC19H17NO5
- CAS number
- 78967-07-4
- Molecular weight
- 339.34
- Formula
- C19H17NO5
- Solubility
- DMSO : 100 mg/mL (294·69 mM; Need ultrasonic)
- InChIKey
- DJEIHHYCDCTAAH-UHFFFAOYSA-N
- Catalogue number
- GC61843
- Brand
- GLPBIO
Computed properties PubChem CID 4237 · XLogP 3.1 · TPSA 81.8 Ų · H-bond donors 1
- XLogP
- 3.1
- TPSA
- 81.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 25
SMILES COC1=CC=C(C=C1)C2=C(ON=C2C3=CC=C(C=C3)OC)CC(=O)O
Computed descriptors from PubChem (CID 4237), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il